Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • suludana
    Member
    • May 2008
    • 61

    #1

    Chip-Seq Data

    Hi,

    I am starting to analyse my first Chip-Seq experiment (using an histone antibody).
    I obtained thousands of peaks.
    After using two filters (read number/peak and control sample no IP) I obtained approximatly 100 peaks per sample. Is it normal? Am I filtering too much?

    Thanks
  • kopi-o
    Senior Member
    • Feb 2008
    • 319

    #2
    In case of histone modifications, regular peak callers may not be appropriate if the modification is diffuse and spread out over large genomic regions. Is that the case here? 100 peaks sounds like a small number. Perhaps your library has a relatively low enrichment over broad regions?

    Comment

    • Nix
      Member
      • Jun 2008
      • 60

      #3
      I'd recommend letting the data tell you how many peaks you have. Use an app that controls for overdispersion and calls p-values using say a negative binomial distribution and also control for multiple testing by converting the p-values to false discovery rates. By setting an FDR of say 1% (and possibly further filtering your list to those likely to have an effect say >2x) then you'll have something to work with that's based on measure of confidence given the noise in your data.

      Check out DESeq and edgeR if you like working with R or USeq (which wraps DESeq) for something a little more user friendly.

      Here's a tutorial I wrote http://useq.sourceforge.net/usage.html

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Working...